Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
M
Value
$222K
Shares
3,015
Price
$73.57
Executed
Nov 7, 2025
Disclosed
Nov 12, 2025
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Nov 7 executedNov 12, 2025 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+12 / 25
$222K reported value · 37.2% of prior position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Gray Nancy Ryan filed this Form 4 reporting a option exercise of LGND on Nov 7, 2025. It became public on Nov 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Gray Nancy Ryancik:0001714949
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
